Back to search

United Kingdom· GB-APID-36745011000001101

Symkevi 100mg/150mg tablets

A ivacaftor and tezacaftor product containing tezacaftor + ivacaftor, registered in United Kingdom by Vertex Pharmaceuticals (Europe) Ltd. The same ATC class is registered in 15 of our 19 countries.

ATC R07AX31

Checked against NHS dm+d (United Kingdom) on

Informational only — not a medical device.

SOURCE REGISTER · GBNHS dm+d (United Kingdom)normalisedSymkevi 100mg/150mg tabletsATCR07AX31REGISTER NO.GB-APID-3674501100000…PACKS LISTED2CHECKEDSeptember 13, 2026

Where it is registered

Ivacaftor and tezacaftor is registered in 15 of 19 countries.

Countries holding a registration under ATC R07AX31 (ivacaftor and tezacaftor), each read from that country’s own register.

  • This record: United Kingdom, from NHS dm+d (United Kingdom)
  • 10 of them publish a price we can compare per daily dose

Ivacaftor and tezacaftor · ATC R07AX31

15 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

NHS dm+d (United Kingdom)
Active substance
Tezacaftor + Ivacaftor
Manufacturer
Vertex Pharmaceuticals (Europe) Ltd
Country
United Kingdom (GB)
ATC code
R07AX31
ATC class
Ivacaftor and tezacaftor
Reimbursed
Not published by this register
Source register
NHS dm+d (United Kingdom)
Last checked
September 13, 2026

Packs & prices · 2

  • gtin
    00351167128800
  • gtin
    00351167151006

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/c4dfd6b4-383d-4d2e-9d82-bdc865b6c457
GET /v1/drugs/c4dfd6b4-383d-4d2e-9d82-bdc865b6c457?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "apid": "36745011000001101",
  "desc": "Symkevi 100mg/150mg tablets (Vertex Pharmaceuticals (Europe) Ltd)",
  "form": "Oral tablet",
  "vpid": "36753011000001104",
  "source": "dmd",
  "vtm_id": "776436003",
  "strength": "150 mg",
  "substance": "Tezacaftor + Ivacaftor",
  "ingredient": "Ivacaftor",
  "supplier_code": "21148411000001105"
}

See everything about ivacaftor and tezacaftor.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.